Figure J. Decreased Susceptibility to Cefixime Among GISP Isolates, 1992-2006
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
| CLINIC | % of isolates | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | |
| ALBUQUERQUE | . | . | 0.6 | . | . | . | . | . | . | . | . | . | . | . | . |
| ATLANTA | 0.4 | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| BALTIMORE | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| BIRMINGHAM | . | . | 0.4 | . | . | . | . | . | . | . | . | . | . | . | . |
| CHICAGO | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| CINCINNATI | 0.8 | 0.8 | . | . | . | 0.5 | . | . | . | . | . | . | . | . | . |
| CLEVELAND | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| DALLAS | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| DENVER | . | . | 0.4 | . | . | . | . | . | . | . | . | . | . | . | . |
| DETROIT | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| GREENSBORO | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| HONOLULU | . | . | . | . | . | . | . | . | . | 3.8 | . | . | . | . | . |
| KANSAS CITY | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| LAS VEGAS | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| LOS ANGELES | . | . | . | . | . | . | . | . | . | . | . | . | 0.7 | . | 0.5 |
| MIAMI | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| MINNEAPOLIS | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| NEW ORLEANS | 0.5 | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| NEW YORK CITY | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| OKLAHOMA CITY | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| ORANGE COUNTY | . | 0.9 | . | 0.7 | . | . | . | . | . | . | . | . | . | . | . |
| PHILADELPHIA | 1.3 | . | . | . | . | 1.3 | 1.3 | . | . | . | . | . | . | . | . |
| PHOENIX | 0.4 | 0.8 | . | 1.3 | . | . | . | . | . | 0.4 | . | . | . | . | . |
| PORTLAND | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| SAN DIEGO | 0.9 | . | . | 0.4 | . | . | . | . | . | . | . | . | . | . | . |
| SAN FRANCISCO | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
| SEATTLE | . | . | . | . | . | . | . | . | . | . | . | . | . | . | . |
Susceptibility testing for cefixime was discontinued in 2007 and 2008.
- Page last reviewed: May 17, 2010 (archived document)
- Content source:
ShareCompartir